A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: Recommendations for service development and implications for palliative care teams

CAR-T therapy is a potentially life-saving treatment for refractory haematological malignancies. As many UK CAR-T services are in their infancy, patient perspectives on service delivery, treatment toxicity and impact on health related quality of life can be perceived as lacking. Charlotte Stenson and Jennifer Vidrine, who have been leading NA-ATTC’s CAR-T Cell Therapy patient-orientated research at The Northern Centre for Cancer Care, carried out a qualitative evaluation aimed to explore the patient and carer experience of CAR-T and identify areas for service improvement and the publication on the results is available beloe.

View evaluation